Molecular landscape and targeted therapy of acute myeloid leukemia

about

Molecular landscape and targeted therapy of acute myeloid leukemia

Item

http://www.wikidata.org/entity/Q59130314

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Molecular landscape and targeted therapy of acute myeloid leukemia

@en

Molecular landscape and targeted therapy of acute myeloid leukemia

@nl

type

Item

label

Molecular landscape and targeted therapy of acute myeloid leukemia

@en

Molecular landscape and targeted therapy of acute myeloid leukemia

@nl

prefLabel

Molecular landscape and targeted therapy of acute myeloid leukemia

@en

Molecular landscape and targeted therapy of acute myeloid leukemia

@nl

P1476

Molecular landscape and targeted therapy of acute myeloid leukemia

@en

P2093

Hui Wei

http://www.w3.org/2001/XMLSchema#string

Runxia Gu

http://www.w3.org/2001/XMLSchema#string

Xue Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.

Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.

RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.

The prognostic significance of IDH2 mutations in AML depends on the location of the mutation.

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

P2888

s40364-018-0146-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40364-018-0146-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30455953

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

6225571

http://www.w3.org/2001/XMLSchema#string